Trice Medical has secured 510(k) approval from the US Food and Drug Administration (FDA) for mi-eye 2, which is a disposable needle with an integrated camera that enables physicians to use advanced diagnostic imaging to visualise joint injuries in their clinic.
Intended for use in diagnostic and operative arthroscopic and endoscopic procedures, mi-eye 2 offers illumination and visualisation of an interior cavity of the body through either a natural or surgical opening.
Go deeper with GlobalData
The mi-eye 2 also offers doctors the ability to inject or aspirate under direct visualisation.
Trice Medical senior president and CEO Jeffrey O'Donnell said: "Based on feedback we received from our surgeon advisory board, we promptly implemented and pursued FDA clearance for the next-generation mi-eye 2.
"Our team made dramatic enhancements to the technology of the mi-eye, which reflects our continued commitment to patients by introducing our technology into a medical practice, and working to ensure that the mi-eye technology becomes the standard of care for providing an immediate real-time diagnosis.
See Also:
"Our long-term goal is to eliminate the need for MRI exams and enable a quicker road to recovery."
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Thank you!
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form
By GlobalDatami-eye 2 is the firm's second, next-generation FDA-cleared patented technology, which includes improvements that bolster the mi-eye's resolution, field of view, depth of field and overall visualisation.
MRI's are often inconclusive, or result in false readings, which has the potential to lengthen the timeline from diagnosis of knee- and shoulder-reated pains to recovery and not every patient is a candidate for MRI.
mi-eye 2 offers a diagnostic modality for every patient, and can provide time-savings to the patient by removing the multiple visits linked with an MRI.
